| abstract |
This invention relates to biotechnology. Methods are proposed for in vitro predicting the risk of death for one year, based on the use of antibodies that bind to human soluble protein, the product of gene 2, expressed during growth promotion (ST2), or their antigen-binding fragments. The proposed group of inventions can be used in medicine. 3 n. and 18 hp f-ly, 11 ill., 10 tablets., 2 ex. |